
9.5 billion won allocated to pediatric, childbirth, and maternal and child medical care in the special account for regional essential medical care
AI-generated summary
Jeju Island will expand support for childbirth medical care starting next year to address the medical gap caused by a decrease in childbirth medical facilities and a shortage of essential medical personnel. With the closure of an obstetrics and gynecology clinic in the province last September, concerns about a gap in childbirth care grew.
Jeju Island will expand support for childbirth medical care starting next year to address the medical gap caused by the decline in childbirth medical facilities and the shortage of essential medical personnel.
Jeju Island announced on the 13th that it will invest 9.5 billion won of the approximately 23.3 billion won allocated as a special account for regional essential medical care in 2027 into the fields of pediatrics, childbirth, and maternal and child medical care.
Among these, a total of KRW 5.08 billion will be provided, including KRW 3.08 billion for childbirth medical care at two general hospitals and KRW 2 billion for three obstetrics and gynecology clinics, to help secure medical personnel and expand facilities and equipment.
This support follows growing concerns about a gap in childbirth care following the closure of an obstetrics and gynecology clinic in the province last September.
The obstetrics and gynecology department was responsible for delivering 237 babies, or 25.6% of all births in the province in the first quarter of this year.
As the number of high-risk mothers increases due to advanced age and multiple pregnancies, transfers of mothers and newborns to other regions are continuing.
The transfer of mothers and newborns to other provinces in the province amounts to a total of 61 cases, including 12 cases in 2023, 10 cases in 2024, 22 cases last year, and 17 cases as of August this year.
The province is strengthening the medical care system for high-risk mothers and newborns, centered on Jeju National University Hospital and Jeju Halla Hospital.
Jeju National University Hospital has expanded the standard for gestational age for delivery from 30 weeks or more to 28 weeks or more since last July, and plans to begin operating a regional maternal and child medical center next month.
In addition, the number of obstetricians will be increased to four by next year, and the intensive care unit for high-risk mothers will be expanded to five beds.
Jeju Halla Hospital has secured two additional obstetricians and gynecologists and is operating a 24-hour delivery care system starting this month, and plans to improve the facilities and equipment of the neonatal intensive care unit next year.
The province plans to prepare a mid- to long-term development plan for the local delivery medical system by the end of the year, concretizing cooperation between medical institutions and measures to secure essential medical personnel.
AI outlook — possibilities, not facts
The number of transfers of high-risk mothers and newborns to other provinces in Jeju Island will decrease.
Possible · Within months
Jeju Island will prepare a mid- to long-term development plan for the local delivery medical system by the end of the year.
Likely · Within months

The competition for GLP-1 type obesity drugs is expanding from injectable to oral. Eli Lilly has received approval for the oral obesity medicine 'Muyuda' in China, and Novo Nordisk is also seeking approval for 'Wegobi Pill' in China. In Korea, two companies have applied for product approval from the Ministry of Food and Drug Safety, and an edible obesity pill is expected to be released in Korea as early as next year.

About one in four deaths in South Korea last year was attributed to cancer, the country's leading cause of death, with 90,203 cancer deaths recorded—a 17.4 percent rise over the past decade. Lung and liver cancers remain the deadliest types, while pancreatic cancer mortality has surged and stomach cancer mortality has fallen. Regional disparities in mortality rates have widened, with Gwangju recording the highest rate and Seoul the lowest.

In Taiwan, the first application for relief from vision loss after using the GLP-1 obesity treatment drug Ozempic was filed. A man in his 50s was diagnosed with NAION after taking the drug for four months, and the Ministry of Food and Drug Safety announced that 12 of the 314 reports of suspected adverse reactions were eye-related.

The Health Insurance Review and Assessment Service announced that 358 victims of the Itaewon disaster and their bereaved families received support for medical expenses, and the related health insurance claim amounted to 1.374 billion won. We continue to provide support for treatment costs for physical and mental aftereffects.

The Seoul Metropolitan Government will invest 707.5 billion won by 2030 to promote a basic plan to support people with developmental disabilities. The key points include introducing a future life plan registration system, establishing autonomous district support centers, and strengthening support by life cycle.

In order to increase accessibility to over-the-counter medicines in areas where it is difficult to purchase medicines, such as military bases, local small and medium-sized airports, and drug-free villages, the government has legislated and administratively announced amendments to the Enforcement Decree of the Pharmaceutical Affairs Act and the Notice on Designation of Handling Medicines in Special Places. This includes allowing direct dispensing by military personnel, proxy handling of medicines for military units in remote areas, and expansion of handling of safety medicines at airport passenger terminals. The revised bill is scheduled to be finalized after collecting opinions.